Your session is about to expire
← Back to Search
Anti-HIV Drug Combinations for HIV
Study Summary
This trial will test the effectiveness and safety of 3 different anti-HIV treatments in patients who have not received treatment before.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Find a Location
Who is running the clinical trial?
Media Library
- I haven't had radiation or chemotherapy in the last 4 weeks and don't expect to need them during the study. Local treatment for Kaposi's sarcoma is okay.I am 18 years old or older.I haven't taken immune system affecting meds or vaccines in the last 4 weeks.I am currently taking St. John's wort.I will use effective birth control during the study.I do not have serious conditions like diabetes or heart problems that make this study unsafe for me.I have not had pancreatitis or hepatitis in the last 6 months.I had an AIDS-related illness but finished treatment over 30 days ago.I have a severe nerve disease that causes muscle weakness.I have taken anti-HIV drugs for less than 2 weeks.I have not received an HIV vaccine in the last 3 months.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this experiment only include young adults in the recruitment process?
"This trial has age restrictions of 18-0, which is different from the 109 other trials for patients under 18 and the 364 trials for patients over 65."
Are there specific inclusion criteria for this research project?
"This study is recruiting 300 patients between the ages of 18 and 0 who currently have hiv infections. Patients must also meet the following criteria:-Pregnant or breast-feeding-Have ever taken anti-HIV drugs (Less than 2 weeks of prior anti-HIV treatment is allowed.)-Have a history of AIDS-defining opportunistic illness (except for Kaposi's sarcoma involving skin) within 45 days of the screening visit. Treatment for the illness must have been completed at least 30 days prior to screening.-Agree to practice effective methods of birth control while on the"
What are the known risks associated with this medication?
"The safety of this treatment is estimated to be a 3, as this is a Phase 4 trial. This means that the treatment has been approved and is available to the public."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger